Revenue, profit growth & strategic insights. CEO transition planned; focus on innovation, partnerships & M&A readiness.

Management reiterated that they are on track to submit their FDA package by the end of 2025, consistent with prior communications. The target remains FDA approval in the first half of 2026. The goal ...

Q1 2025 Management View CEO Yang Wu highlighted "record first-quarter revenue with 43% growth year-over-year, delivering $116 ...

Life360 has reported quarterly revenue and earnings exceeding consensus expectations. The company added 137,000 customers - a ...

Q1 2025 Management View CEO Josh Resnik reported, "We are pleased to report adjusted EBITDA of $2.8 million in the first quarter of this year exceeding expectations." He outlined a disciplined ...